Literature DB >> 10606314

Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease.

S C Bischoff1, J Mayer, Q T Nguyen, M Stolte, M P Manns.   

Abstract

OBJECTIVE: To assess the activation grade of intestinal eosinophils in patients with eosinophilic gastroenteritis (EOG), ulcerative colitis (UC), Crohn's disease (CD), and controls by immunohistochemistry.
METHODS: Cecal biopsies were collected from healthy controls and from patients with EOG, CD, UC, and other noninflammatory GI diseases. Immunohistochemistry was performed in sequential sections stained with monoclonal antibodies directed against eosinophil cationic protein (ECP) or eosinophil protein X (EPX) stored in eosinophil granules (EG1) and that secreted by activated eosinophils (EG2). The ratio of EG1 to EG2-positive eosinophils expressed as percentage of lamina propria cells was calculated. ECP and EPX were measured in serum and feces.
RESULTS: The percentage of EG1 and EG2-positive lamina propria cells was elevated in EOG and slightly, but not significantly, in UC. The ratio of EG1 to EG2-positive cells was decreased in CD, UC, and other patients as compared to healthy controls. Particularly low EG1 to EG2 ratios were found in EOG. Correspondingly, fecal and serum levels of ECP and EPX, respectively, were highest in patients with EOG. The EG1 to EG2 ratio was negatively correlated with fecal ECP and EPX levels. At sites of actively inflamed mucosa, the EG1 to EG2 ratio was lower than in noninflamed tissue.
CONCLUSIONS: Our data strongly suggest that the EG1 to EG2 ratio may be a marker of tissue eosinophil activation. Low ratios (<1) indicate eosinophil activation, whereas ratios > or =1 are found in healthy controls. Furthermore, we show that EOG is characterized by a pronounced intestinal eosinophil accumulation and activation, whereas in CD and UC, eosinophils seem to be activated but their number is not or only slightly elevated compared to controls.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10606314     DOI: 10.1111/j.1572-0241.1999.01641.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  23 in total

Review 1.  Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis.

Authors:  Eduardo Garcia Vilela; Henrique Osvaldo da Gama Torres; Fabiana Paiva Martins; Maria de Lourdes de Abreu Ferrari; Marcella Menezes Andrade; Aloísio Sales da Cunha
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

2.  Colonic eosinophilic inflammation in experimental colitis is mediated by Ly6C(high) CCR2(+) inflammatory monocyte/macrophage-derived CCL11.

Authors:  Amanda Waddell; Richard Ahrens; Kris Steinbrecher; Burke Donovan; Marc E Rothenberg; Ariel Munitz; Simon P Hogan
Journal:  J Immunol       Date:  2011-04-15       Impact factor: 5.422

3.  Eosinophilic ascites, an unusual presentation of eosinophilic gastroenteritis: A case report and review.

Authors:  Iryna S Hepburn; Subbaramiah Sridhar; Robert R Schade
Journal:  World J Gastrointest Pathophysiol       Date:  2010-12-15

Review 4.  Roles and regulation of gastrointestinal eosinophils in immunity and disease.

Authors:  YunJae Jung; Marc E Rothenberg
Journal:  J Immunol       Date:  2014-08-01       Impact factor: 5.422

5.  Tissue eosinophilia in a mouse model of colitis is highly dependent on TLR2 and independent of mast cells.

Authors:  Eric J Albert; Jon Duplisea; Wojciech Dawicki; Ian D Haidl; Jean S Marshall
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

6.  Eosinophilic Gastroenteritis: Clinical Manifestation, Natural Course, and Evaluation of Treatment with Corticosteroids and Vedolizumab.

Authors:  Tanja Grandinetti; Luc Biedermann; Christian Bussmann; Alex Straumann; Petr Hruz
Journal:  Dig Dis Sci       Date:  2019-04-13       Impact factor: 3.199

Review 7.  Eosinophilic gastroenteritis.

Authors:  Rahim Daneshjoo; Nicholas J Talley
Journal:  Curr Gastroenterol Rep       Date:  2002-10

8.  Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis.

Authors:  Richard Ahrens; Amanda Waddell; Luqman Seidu; Carine Blanchard; Rebecca Carey; Elizabeth Forbes; Maria Lampinen; Tara Wilson; Elizabeth Cohen; Keith Stringer; Edgar Ballard; Ariel Munitz; Huan Xu; Nancy Lee; James J Lee; Marc E Rothenberg; Lee Denson; Simon P Hogan
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

Review 9.  Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome.

Authors:  Jan Däbritz; Jason Musci; Dirk Foell
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

10.  Heightened Immune Activation in Fetuses with Gastroschisis May Be Blocked by Targeting IL-5.

Authors:  Michela Frascoli; Cerine Jeanty; Shannon Fleck; Patriss W Moradi; Sheila Keating; Aras N Mattis; Qizhi Tang; Tippi C MacKenzie
Journal:  J Immunol       Date:  2016-05-13       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.